ASCO 2013 Gu Intro

Elucidating Non-Invasive Radiosurgery Advancements in CNS Tumors

Data show that patients who undergo grade group 1 prostatectomies may experience an increased likelihood of higher risk features.

A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.

William R. Kennedy, MD

April 28th 2025

Pelvic Radiation Confers More Complications After Bladder Cancer Surgery

A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.

"[These] data provide framework to assist in patient counseling and optimizing selection," according to the study authors.

Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care

Findings may establish a framework for assisting patient counselling and optimizing therapy selection for those undergoing radical cystectomy.

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS

April 21st 2025

Organ Preservation Noted With Neoadjuvant Dostarlimab in dMMR Tumors

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Caroline Seymour

Zanidatamab Recommended For Conditional Marketing Approval in Advanced HER2+ BTC

A phase 2 study found a complete clinical response of 82% with neoadjuvant dostarlimab in dMMR solid tumors.

The recommendation from the CHMP is based on results from the phase 2b HERIZON-BTC-01 trial of zanidatamab in advanced HER2+ biliary tract cancer.

Roman Fabbricatore

Surgical Overtreatment Has Declined in Grade Group 1 Prostate Cancer

The recommendation from the CHMP is based on results from the phase 2b HERIZON-BTC-01 trial of zanidatamab in advanced HER2+ biliary tract cancer.

Related Content

Elucidating Non-Invasive Radiosurgery Advancements in CNS Tumors

Data show that patients who undergo grade group 1 prostatectomies may experience an increased likelihood of higher risk features.

William R. Kennedy, MD

April 28th 2025

Pelvic Radiation Confers More Complications After Bladder Cancer Surgery

A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.

Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care

Findings may establish a framework for assisting patient counselling and optimizing therapy selection for those undergoing radical cystectomy.

Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS

April 21st 2025

Organ Preservation Noted With Neoadjuvant Dostarlimab in dMMR Tumors

Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.

Caroline Seymour

Zanidatamab Recommended For Conditional Marketing Approval in Advanced HER2+ BTC

A phase 2 study found a complete clinical response of 82% with neoadjuvant dostarlimab in dMMR solid tumors.

Roman Fabbricatore